Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sickle cell disease 115 years later: improving health outcomes through policy, research, and collaboration, to achieve health equity.

Frontiers in health services·2026
Same author

Trends in National Institutes of Health Investigators by Sex, Race, Ethnicity, and Disability Status.

JAMA·2026
Same author

Uptake of HIV Self-testing Among Adolescents and Young Adults in Nigeria: A Secondary Observational Analysis of a Stepped-Wedge, Cluster-Randomized Trial.

AIDS and behavior·2026
Same author

Experiences shaping research career intention among Black, Hispanic, and Indigenous-identifying first-year allopathic medical students in the United States: A qualitative study.

PloS one·2026
Same author

Unequal paths to care: How region, rurality, and deprivation determine transport to verified trauma centers among the critically injured.

Surgery·2026
Same author

Association between high likelihood of obstructive sleep apnea and masked hypertension: findings from the Jackson heart and coronary artery risk development in young adults studies.

Journal of hypertension·2026
Same journal

Visit-to-Visit Systolic Blood Pressure Variability Predicts Long-Term Cardiovascular Events After Coronary Artery Bypass Grafting.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Impact of Maternal Risk Stratification on Clinical Characteristics and Perinatal Outcomes in Singleton Pregnancies With Preeclampsia.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Antihypertensive Efficacy, Safety, and Adherence After Switching From a Free Combination of Bisoprolol/Metoprolol and Amlodipine to Bisoprolol/Amlodipine FDC Tablets (5/5 mg) in Chinese Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Blood Pressure Variability in Acute Ischemic Stroke: Current Evidence, Measurement Challenges, and Future Directions.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Association of Triglyceride-Glucose Index, Triglyceride/HDL Cholesterol Ratio and Metabolic Score for Insulin Resistance With Asymptomatic Organ Damage in Previously Untreated Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Letter to the Editor Regarding: "Associations of High-Sensitivity Cardiac Troponin and N-Terminal Pro-B-Type Natriuretic Peptide With Echocardiographic Features in Patients With Hypertension".

Journal of clinical hypertension (Greenwich, Conn.)·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Barriers to optimal hypertension control.

Gbenga Ogedegbe1

  • 1Department of Medicine ,Columbia University, New York, NY 10032, USA. goo1@columbia.edu

Journal of Clinical Hypertension (Greenwich, Conn.)
|September 6, 2008
PubMed
Summary
This summary is machine-generated.

Bridging the gap in hypertension control requires addressing patient adherence and physician clinical inertia. Overcoming these barriers is crucial for effective blood pressure management and patient outcomes.

Related Experiment Videos

Last Updated: Jul 2, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • A significant gap exists in translating clinical trial evidence into practice for optimal hypertension management.
  • Barriers to blood pressure (BP) control are categorized into patient-related, physician-related, and healthcare system factors.

Purpose of the Study:

  • To identify and analyze the primary barriers hindering effective hypertension control in clinical practice.
  • To highlight the critical role of medication adherence and physician clinical inertia.

Main Methods:

  • Review of existing literature and clinical guidelines on hypertension management.
  • Categorization and analysis of identified barriers to blood pressure control.

Main Results:

  • Patient-related barriers include poor medication adherence, beliefs, depression, health literacy, comorbidity, and motivation.
  • Physician-related barriers are dominated by clinical inertia, defined as failure to initiate or intensify therapy for uncontrolled BP.
  • Reasons for clinical inertia include overestimation of care provided, lack of training, and avoidance of treatment intensification.

Conclusions:

  • Improving hypertension control necessitates addressing patient adherence and physician clinical inertia.
  • Strategies must target patient-specific issues and physician behaviors to enhance treatment intensification and achieve target BP levels.